Home » Topics » Regulatory

Regulatory
RSS

Canadian authorities approve use of Fragmin in treatment of heart disease

Aug. 31, 1998

Hoechst Marion Roussel and 3M file NDA for QVAR

Aug. 28, 1998

CIBIS-II study results confirm benefits of beta-blockade in heart failure

Aug. 27, 1998

FDA approves first treatment for Crohn's disease

Aug. 27, 1998

MOXCON study will test the efficacy of SIRAs in treating heart failure

Aug. 27, 1998

SSRI produces significant improvements in patients with social phobia

Aug. 26, 1998

First approval for lamivudine in chronic hepatitis B

Aug. 25, 1998

New indication approved for AmBisome in the U.K.

Aug. 24, 1998

Thymosin alpha 1 receives patent protection for hepatitis C indication

Aug. 24, 1998

Canadian launch announced for Zyban sustained-release tablets

Aug. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026